Bharat Immunologicals & Biologicals Corporation Fundamentals is currently trading with a P/E Ratio of 0, compared to the sector average of 36.99. Its P/B Ratio stands at 0, while the sector’s is 3.63. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.56%.
On its scorecard, Bharat Immunologicals & Biologicals Corporation reflects: Price – Attractive, Growth – Average, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.